Compare ACOG & ELMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ACOG | ELMD |
|---|---|---|
| Founded | 2000 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 193.6M | 226.4M |
| IPO Year | 2024 | 2010 |
| Metric | ACOG | ELMD |
|---|---|---|
| Price | $9.26 | $27.91 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 2 |
| Target Price | $18.00 | ★ $48.50 |
| AVG Volume (30 Days) | ★ 96.6K | 47.0K |
| Earning Date | 11-12-2026 | 11-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 41.58 | ★ 52.94 |
| EPS | N/A | ★ 1.30 |
| Revenue | $10,220,275.00 | ★ $54,716,000.00 |
| Revenue This Year | $153.46 | $12.71 |
| Revenue Next Year | $85.72 | $10.70 |
| P/E Ratio | ★ N/A | $21.22 |
| Revenue Growth | N/A | ★ 13.83 |
| 52 Week Low | $4.50 | $23.01 |
| 52 Week High | $10.14 | $47.40 |
| Indicator | ACOG | ELMD |
|---|---|---|
| Relative Strength Index (RSI) | 58.69 | 48.39 |
| Support Level | $7.50 | $27.18 |
| Resistance Level | $9.48 | $28.55 |
| Average True Range (ATR) | 0.46 | 0.77 |
| MACD | 0.07 | 0.14 |
| Stochastic Oscillator | 85.44 | 71.08 |
Alpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimers disease, for which there are limited or no treatment options. The Companies current focus is on the commercial manufacturing and sales of ZUNVEYL oral tablet formulation. The Companies commercial development program for ZUNVEYL is focused on building a long-term care commercial team that can focus on providing key points of differentiation, exploiting key issues with existing Acetylcholinesterase inhibitors treatments, and seeking potential licensing partners for other additional indications and new formulations.
Electromed Inc is a United States-based company that develops, manufactures and markets airway clearance products that apply High Frequency Chest Wall Oscillation (HFCWO) therapy in pulmonary care for patients of all ages. The company markets its products in the U.S. to the homecare and hospital markets. Its product includes the SmartVest Airway Clearance System and related products, to patients with compromised pulmonary function with a commitment to excellence and compassionate service. The company operates in a single segment: developing, manufacturing, and marketing medical equipment. The company generates revenue from Homecare, Hospital, Homecare Distributor, and Other.